Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.8%

227 terminated/withdrawn out of 1144 trials

Success Rate

73.1%

-13.4% vs industry average

Late-Stage Pipeline

15%

170 trials in Phase 3/4

Results Transparency

55%

340 of 618 completed trials have results

Key Signals

171 recruiting340 with results119 terminated108 withdrawn

Enrollment Performance

Analytics

N/A
437(48.6%)
Phase 2
163(18.1%)
Phase 4
126(14.0%)
Phase 1
99(11.0%)
Phase 3
44(4.9%)
Early Phase 1
31(3.4%)
900Total
N/A(437)
Phase 2(163)
Phase 4(126)
Phase 1(99)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1144)

Showing 20 of 1144 trials
NCT02645487Not ApplicableActive Not Recruiting

Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis

Role: lead

NCT04796012Phase 1Recruiting

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Role: lead

NCT02468024Phase 3Recruiting

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Role: lead

NCT06768905Phase 1Recruiting

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

Role: lead

NCT03935282Not ApplicableCompleted

Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

Role: collaborator

NCT05576974Phase 2Recruiting

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Role: lead

NCT06044857Phase 1Recruiting

PSMA PET Response Guided SabR in High Risk Pca

Role: lead

NCT07280702Phase 4Not Yet Recruiting

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

Role: lead

NCT05129020Not ApplicableActive Not Recruiting

Neurostimulation to Improve NOWS Outcomes

Role: collaborator

NCT05966532Active Not Recruiting

Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression

Role: lead

NCT07064174Recruiting

Sickle Cell Kidney Biorepository

Role: lead

NCT07228338Early Phase 1Not Yet Recruiting

Cholinergic Enhancement of Theta

Role: lead

NCT04844359Active Not Recruiting

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

Role: collaborator

NCT03707431Not ApplicableCompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Role: collaborator

NCT02138669Not ApplicableRecruiting

Intacs Prescription Inserts for Keratoconus Patients

Role: lead

NCT05478694Recruiting

Outcomes of Focal Ablation for Prostate Cancer

Role: lead

NCT07041775Not ApplicableNot Yet Recruiting

MINT Conditioning to Improve Gait

Role: collaborator

NCT06496750Phase 2Recruiting

Ketamine for Methamphetamine Use Disorder

Role: lead

NCT07494812Not ApplicableNot Yet Recruiting

Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials

Role: lead

NCT06924177Not ApplicableRecruiting

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Role: lead